Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures

Published:2013-08-16 Issue:3 Volume:27 Page:433-442
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Curry Edward WJ,Stronach Euan A,Rama Nona R,Wang Yuepeng YP,Gabra Hani,El-Bahrawy Mona A

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2013130.pdf

Reference26 articles.

1. Lenhard MS, Mitterer S, Kumper C et al. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur J Obstet Gynecol Reprod Biol 2009;145:189–194.

2. Jones MB . Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol 2006;49:517–525.

3. Manek S, Wells M . Pathology of borderline ovarian tumours. Clin Oncol (R Coll Radiol) 1999;11:73–77.

4. Morice P, Camatte S, Rey A et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol 2003;14:592–598.

5. Seidman JD, Kurman RJ . Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539–557.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Approach to Molecular Profiling of the Transition from Ovarian Epithelial Cells to Low-Grade Serous Ovarian Tumors for Targeted Therapeutic Insights;Current Issues in Molecular Biology;2024-02-26

2. Molecular landscape of borderline ovarian tumours: A systematic review;Open Medicine;2024-01-01

3. Usefulness of COL11A1 as a Prognostic Marker of Tumor Infiltration;Biomedicines;2023-09-08

4. Ovarian Cancer Pathology;Advances in Diagnosis and Management of Ovarian Cancer;2022

5. Multiomics Characterization of Potential Therapeutic Vulnerabilities in Low-grade Serous Ovarian Carcinoma;2020-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3